...
首页> 外文期刊>Bone marrow transplantation >Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).
【24h】

Successful autologous peripheral blood stem cell transplantation in transformed follicular lymphoma previously treated with radioimmunotherapy (iodine (131)I tositumomab).

机译:成功进行放射免疫疗法治疗的转化滤泡性淋巴瘤的自体外周血干细胞移植成功(碘(131)I tositumomab)。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While the use of radioimmunotherapy for lymphoma increases, the feasibility and efficacy of autologous stem cell transplant for subsequent relapse remains unknown. We report a 48-year-old male with transformed follicular mixed non-Hodgkin's lymphoma. After treatment with three different combination chemotherapy regimens, at relapse he received radioimmunotherapy with iodine (131)I tositumomab (anti-CD20), with very good response. At later relapse, a second course of (131)I tositumomab was given unsuccessfully. He underwent peripheral blood stem cell harvest, chemoradiotherapy conditioning and autologous transplantation with prompt engraftment and without significant complications. He remains in complete remission with normal blood counts 25 months post autograft.
机译:尽管放射免疫疗法对淋巴瘤的使用有所增加,但自体干细胞移植治疗随后复发的可行性和功效仍未知。我们报告了一名48岁男性,患有转化的滤泡性混合非霍奇金淋巴瘤。在使用三种不同的联合化疗方案治疗后,复发时,他接受了碘(131)I托西单抗(抗CD20)放射免疫疗法,反应良好。在后来的复发中,未成功给予(131)I tositumomab的第二个疗程。他接受了外周血干细胞收获,化学放疗调理和自体移植,植入迅速,无明显并发症。自体移植后25个月,他保持完全缓解,血液计数正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号